UBS Group »

Bridgebio Pharma shares owned by UBS Group

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $40M 986k 40.37
2023-09-30 $4.0M 153k 26.37
2023-06-30 $3.0M 175k 17.20
2023-03-31 $1.4M 85k 16.58
2022-12-31 $2.7M 360k 7.62
2022-09-30 $86k 8.8k 9.70
2022-06-30 $2.0M 221k 9.07
2022-03-31 $4.5M 442k 10.15
2021-12-31 $1.2M 73k 16.69
2021-09-30 $5.3M 113k 46.87
2021-06-30 $0 22k 0.00
2021-03-31 $822k 13k 61.61
2020-12-31 $1.3M 19k 69.60
2020-09-30 $686k 18k 37.50
2020-06-30 $631k 19k 32.61
2020-03-31 $462k 16k 29.02
2019-12-31 $633k 18k 35.07
2019-09-30 $723k 34k 21.45
2019-06-30 $16k 600 26.67